Platelet-rich fibrin a new approach in management of persistent oral ulcers in blistering skin diseases
Document Type
Article
Publication Date
5-10-2022
Abstract
The present study designed to evaluate the healing power of platelet-rich fibrin (PRF) in terms of pain control and mucosal repair. A randomised, controlled, pilot clinical trial was conducted on 16 patients randomly distributed with 1:1 allocation ratio into two groups. The treatment group received PRF minced and mixed with orabase and the control group received clobetasol propionate 0.05% mixed with orabase. Pain reduction was evaluated as primary outcome along with mucositis healing as secondary outcome. A statistically significant difference in pain reduction was observed between the two groups (p ≤ 0.05). The clinical results at Day 7 has shown that PRF group had 100% pain reduction while, CP group had 32.5% reduction from base line. PRF offered superior clinical results providing rapid pain alleviation and accelerated ulcer healing compared to corticosteroids.
Recommended Citation
Ahmed EM, Shafik S, El Saadany B. Platelet-rich fibrin a new approach in management of persistent oral ulcers in blistering skin diseases. Wound repair and regeneration: official publication of the Wound Healing Society [and] the European Tissue Repair Society. 2022 Jun 3.